A Phase I Clinical Study of HLX53 in Advanced/Metastatic Solid Tumors
Clinical trial NCT05394168 · UNKNOWN
Trial details
- NCT number
- NCT05394168
- Sponsor
- Shanghai Henlius Biotech
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-09
- Primary completion
- 2024-12-04
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.